← All stocks

Bristol Myers Squibb

BMY Net selling
CIK 0000014272 #77 in the set updated 17 Sep 2026
Bought (120 mo)
$3.93M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$152.30M
$0.00 on a plan · $54.37M straight out of an exercise
Sold at will
$97.93M
62 of 76 sales
Net
−$148.37M
−$94.00M against sales at will

By person

42 insiders · 101 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Caforio Giovanni
Executive Chair of the Board
$36.21M (10)
−$36.21M
432,266
$27.91M
+235.9%
Vessey Rupert
EVP & President, Research
$35.57M (13) scheduled
−$35.57M
48,364
$3.12M
LEUNG SANDRA
EVP, General Counsel
$31.00M (5)
−$31.00M
457,732
$29.56M
+24.4%
Elkins David V
EVP, Chief Financial Officer
$20.73M (7) scheduled
−$20.73M
159,443
$10.30M
Powell Ann
EVP, Chief Human Resources
$6.61M (5)
−$6.61M
27,868
$1.80M
+13.5%
von Autenried Paul
EVP, Chief Information Officer
$5.88M (6)
−$5.88M
63,536
$4.10M
−30.0%
Schmukler Louis S
EVP,Pres.,Glob.Prod. & Supply
$5.09M (5)
−$5.09M
31,956
$2.06M
+45.4%
ANDREOTTI LAMBERTO
Director
$3.72M (4)
−$3.72M
935,571
$60.41M
+412.8%
Samuels Theodore R. II
Director
$1.93M (5)
+$1.93M
35,500
$2.29M
Elicker John E
EVP, Investor Relations
$1.81M (2)
−$1.81M
70,946
$4.58M
+29.0%
BOERNER CHRISTOPHER S.
Chief Executive Officer
$359.71K (3)
$2.04M (1)
−$1.68M
149,764
$9.67M
+5,111%
Caldarella Joseph C
SVP & Controller
$1.02M (2)
−$1.02M
46,297
$2.99M
−16.2%
Paliwal Dinesh C
Director
$749.93K (2)
+$749.93K
22,109
$1.43M
+170.8%
Dubow Adam
SVP,ChiefCompliance&EthicsOff.
$722.32K (5)
−$722.32K
13,777
$889.59K
−6.3%
Santiago Karen Murphy
SVP & Controller
$600.87K (2)
−$600.87K
16,704
$1.08M
+4,045%
BERTOLINI ROBERT J
Director
$491.92K (1)
+$491.92K
11,397
$735.90K
+2,771%
Eid Joseph
SVP,Head Glob. Medical Affairs
$413.60K (2)
−$413.60K
9,485
$612.45K
+173.3%
Massacesi Cristian
EVP,Chief Med Offr,Head of Dev
$403.50K (1)
−$403.50K
18,748
$1.21M
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
$402.27K (3)
+$402.27K
83,513
$5.39M
Lynch Thomas J. Jr.
EVP & Chief Scientific Officer
$335.17K (1)
−$335.17K
22,223
$1.43M
Holzer Phil M
SVP and Controller
$72.68K (2)
−$72.68K
16,862
$1.09M
+68.4%
Plenge Robert M
EVP, Chief Research Officer
$44.75K (1)
−$44.75K
21,528
$1.39M
+194.3%
Short Bartie Wendy
EVP, Corporate Affairs
$16.72K (1) scheduled
−$16.72K
12,684
$819.01K
BONNEY MICHAEL W
Director
$5.18K (1)
+$5.18K
12,501
$807.19K
+201.1%
Hickey Benjamin
President, RayzeBio Org.
$3.70K (1)
−$3.70K
16,672
$1.08M
+1,800%
Bancroft Charles A
EVP, Head of Integration
437,534
$28.25M
+141.7%
Cuss Francis M
EVP & CSO
321,906
$20.79M
+11.1%
Gordon Murdo
EVP, Chief Commercial Officer
49,424
$3.19M
+241.7%
AHMED NADIM
EVP and President, Hematology
40,855
$2.64M
Nielsen Anne
Chief Compliance & Ethics Off
37,974
$2.45M
+31.5%
Mily Elizabeth
EVP, Strategy & BD
34,734
$2.24M
Haller Julia A
Director
34,079
$2.20M
+1,315%
Meyers Gregory Scott
EVP, Chief Digital & Tech Off.
30,361
$1.96M
Shanahan Karin
EVP, Chief Supply Chain & Ops
25,888
$1.67M
Blin Emmanuel
SVP, Chief Strategy Officer
20,138
$1.30M
+63.8%
Lenkowsky Adam
EVP, Chief Commercial Officer
19,706
$1.27M
Gallman Cari
EVP, General Counsel
13,649
$881.32K
+6,526%
Hoch Lynelle
President, Cell Therapy Org.
8,210
$530.12K
Poole Ahn Amanda
EVP, Chief People Officer
7,094
$458.06K
Biondi Paul
SVP, Head of Strategy & BD
6,214
$401.24K
Weese Michelle
EVP, Corporate Affairs
3,453
$222.96K
Greenlees Sharon
SVP & Controller
609
$39.32K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Hirawat Samit
25 Apr 2025
EVP,Chief Med.Offr.,Drug Dev.
Buy
4,250
$47.58
$202.22K
BOERNER CHRISTOPHER S.
20 Feb 2025
Chief Executive Officer
Buy
2,000
$55.05
$110.10K
Hirawat Samit
14 Feb 2025
EVP,Chief Med.Offr.,Drug Dev.
Buy
1,823
$54.84
$100.00K
Hirawat Samit
1 Nov 2024
EVP,Chief Med.Offr.,Drug Dev.
Buy
1,830
$54.68
$100.06K
BOERNER CHRISTOPHER S.
5 Dec 2023
Chief Executive Officer
Buy
2,000
$49.78
$99.56K
BOERNER CHRISTOPHER S.
28 Nov 2023
Chief Executive Officer
Buy
3,071
$48.86
$150.05K
Samuels Theodore R. II
20 Nov 2023
Director
Buy
8,500
$49.81
$423.39K
Paliwal Dinesh C
15 Jun 2020
Director
Buy
9,174
$54.50
$499.98K
BONNEY MICHAEL W
4 Dec 2019
Director
Buy
88
$58.90
$5.18K
BERTOLINI ROBERT J
31 Jul 2019
Director
Buy
11,000
$44.72
$491.92K
Samuels Theodore R. II
16 May 2019
Director
Buy
5,000
$47.29
$236.44K
Paliwal Dinesh C
30 Apr 2018
Director
Buy
4,770
$52.40
$249.95K
Samuels Theodore R. II
15 Dec 2017
Director
Buy
4,000
$62.30
$249.19K
Samuels Theodore R. II
2 Aug 2017
Director
Buy
6,000
$55.94
$335.62K
Samuels Theodore R. II
27 Feb 2017
Director
Buy
12,000
$56.77
$681.24K

What was left out

Form 4 filings counted 806
Amendments (4/A) skipped 12
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 14
Sales at will 62
Transactions with no price 0
Shares from compensation/vesting 11,985,719
Sales filed before the plan box existed 52
History held since 7 Sep 2016